Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

McMaster University

$497,822.00

The INternational ORthopaedic Multi-centre Study in Fracture Care (INORMUS): A Multi-centre Prospective Cohort Study

EF 2013-14

Résumé
Trauma is the leading cause of death in the first four decades of life surpassed only by cancer and atherosclerosis. For every person killed as a result of an injury, multiple individuals are left permanently disabled. The vast majority of trauma occurs outside of North America. Musculoskeletal injuries, such as fractures and dislocations, are very common manifestations of trauma occurring in over 60% of victims. Orthopaedic injuries are likely the greatest trauma burden worldwide; however, large prospective studies evaluating musculoskeletal injury burden in developing nations are limited due to poor resources and high trauma volumes. Given the degree of human suffering and societal costs associated with musculoskeletal trauma, there is a need to identify modifiable factors associated with complications. We propose the International Orthopaedic Multi-centre Study in Fracture Care (INORMUS) which is a large prospective cohort study of 40,000 men and women with musculoskeletal trauma in low-middle countries (LMICs). The purpose of INORMUS is to determine the frequency of major complications (i.e. deaths, re-operations, and infections) following a musculoskeletal injury (i.e. fracture of a bone or dislocation of a joint), and to determine factors associated these major complications. INORMUS will include 40 clinical sites from China, Africa, India/Nepal, Southeast Asia, and Latin America. Our proposal is strengthened by a simple design, our ability to recruit a sufficiently large sample of patients in countries with high volumes of musculoskeletal trauma, a qualified and highly collaborative international team of researchers and surgeons, and a successful pilot feasibility study. The results of INORMUS will not only inform prognostic factors for outcomes following orthopaedic injuries in LMICs, but provide important insight towards the development of clinical trials to test simple, life and limb saving interventions applicable to injured patients around the world.
Programme
Operating Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
292745
Name
Bhandari Mohit
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Health Services Evaluation & Interventions Research
Projecttitle
The INternational ORthopaedic Multi-centre Study in Fracture Care (INORMUS): A Multi-centre Prospective Cohort Study
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$497,822
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
International; Low-Middle Income Countries; Orthopaedic; Prospective Cohort
Abstract
Trauma is the leading cause of death in the first four decades of life surpassed only by cancer and atherosclerosis. For every person killed as a result of an injury, multiple individuals are left permanently disabled. The vast majority of trauma occurs outside of North America. Musculoskeletal injuries, such as fractures and dislocations, are very common manifestations of trauma occurring in over 60% of victims. Orthopaedic injuries are likely the greatest trauma burden worldwide; however, large prospective studies evaluating musculoskeletal injury burden in developing nations are limited due to poor resources and high trauma volumes. Given the degree of human suffering and societal costs associated with musculoskeletal trauma, there is a need to identify modifiable factors associated with complications. We propose the International Orthopaedic Multi-centre Study in Fracture Care (INORMUS) which is a large prospective cohort study of 40,000 men and women with musculoskeletal trauma in low-middle countries (LMICs). The purpose of INORMUS is to determine the frequency of major complications (i.e. deaths, re-operations, and infections) following a musculoskeletal injury (i.e. fracture of a bone or dislocation of a joint), and to determine factors associated these major complications. INORMUS will include 40 clinical sites from China, Africa, India/Nepal, Southeast Asia, and Latin America. Our proposal is strengthened by a simple design, our ability to recruit a sufficiently large sample of patients in countries with high volumes of musculoskeletal trauma, a qualified and highly collaborative international team of researchers and surgeons, and a successful pilot feasibility study. The results of INORMUS will not only inform prognostic factors for outcomes following orthopaedic injuries in LMICs, but provide important insight towards the development of clinical trials to test simple, life and limb saving interventions applicable to injured patients around the world.
Competitiondate
201309
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bhandari, Mohit
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $497,822~ $0~